摘要
动脉粥样硬化是急性心血管疾病的主要病理生理过程。危险的生命状况,如心肌梗死和缺血性中风,是由脆弱的动脉粥样硬化斑块的突然破裂,其特点是薄、高度发炎和胶原纤维。而先天和适应性炎症逐渐成为这个过程的驱动力,更是对中性粒细胞(PMN)的参与。在过去的二十年里,中性粒细胞在不同的酶的释放促进斑块易损性中起到重要的作用,实验技术的进步,如明胶酶(基质金属蛋白酶)和胶原酶,弹性蛋白酶髓过氧化物酶的使用。因此,中性粒细胞及其产物的循环水平的研究已在一级和二级预防斑块的不稳定性对心血管疾病的潜在标志物。此外,不同类别的针对中性粒细胞活化药物的开发正在成为一个有趣的研究领域。本综述将提供对中性粒细胞在促进斑块的易损性也讨论治疗策略针对中性粒细胞在斑块易损性的潜在影响的更新。
关键词: 动脉粥样硬化,炎症,基质金属蛋白酶,髓过氧化物酶,中性粒细胞,易损斑块。
图形摘要
Current Drug Targets
Title:Update on the Role of Neutrophils in Atherosclerotic Plaque Vulnerability
Volume: 16 Issue: 4
Author(s): Federico Carbone, Francois Mach and Fabrizio Montecucco
Affiliation:
关键词: 动脉粥样硬化,炎症,基质金属蛋白酶,髓过氧化物酶,中性粒细胞,易损斑块。
摘要: Atherosclerosis is the main pathophysiological process underlying acute cardiovascular diseases. Life-threatening conditions, such as myocardial infarction and ischemic stroke, are provoked by the sudden rupture of vulnerable atherosclerotic plaques, characterized by thin, highly inflamed and collagen-poor fibrous cap. Whereas both innate and adaptive inflammation progressively emerged as driving force of this processes, less is known about the involvement of neutrophils (PMNs). Advances in laboratory techniques during the last two decades disclosed that PMNs play a crucial role in promoting plaque vulnerability by the release of different enzymes, such as gelatinases (matrix metalloproteinases) collagenases, elastase and myeloperoxidase. Accordingly, circulating levels of PMNs and their products have been investigated as potential markers of plaque instability in both primary and secondary prevention on cardiovascular diseases. In addition, the development of different classes of drugs targeting PMNs activation is emerging as an interesting field of research. This narrative review will provide an update on the role of PMNs in promoting plaque vulnerability also discussing the potential effects of therapeutic strategies targeting PMN on plaque vulnerability.
Export Options
About this article
Cite this article as:
Federico Carbone, Francois Mach and Fabrizio Montecucco , Update on the Role of Neutrophils in Atherosclerotic Plaque Vulnerability, Current Drug Targets 2015; 16 (4) . https://dx.doi.org/10.2174/1389450115666141110093013
DOI https://dx.doi.org/10.2174/1389450115666141110093013 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Journals
Related Books
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Need for Diagnostic Criteria in Systemic Vasculitis
Current Immunology Reviews (Discontinued) Left Ventricular Noncompaction: New Insights into a Poorly Understood Disease
Current Cardiology Reviews Myocardial Revascularization Strategies in Diabetic Patients with Multi-Vessel Disease: CABG vs DES-Based PCI
Current Pharmaceutical Design Unmasking Sex-Based Disparity in Neuronal Metabolism
Current Pharmaceutical Design Von Willebrand Factor and Cardiovascular Disease: From a Biochemical Marker to an Attractive Therapeutic Target
Current Vascular Pharmacology Is There An Association Between Vitamin D and Hypertension?
Recent Patents on Cardiovascular Drug Discovery Haematopoietic Stem Cell Gene Therapy to Treat Autoimmune Disease
Current Stem Cell Research & Therapy Plant Terpenes on Treating Cardiovascular and Metabolic Disease: A Review
Protein & Peptide Letters Gesture Interaction for Coronary Heart Diseases Based on Wavelet Transform and Semi-Continuous Hidden Markov Model in Augmented Reality
Recent Advances in Electrical & Electronic Engineering Editorial [Hot Topic (1): Update on Inflammatory Processes Governing Atherosclerotic Plaque Vulnerability and Reperfusion Injury (Guest Editors: Fabrizio Montecucco and Francois Mach)]
Current Pharmaceutical Biotechnology Homocysteine and Non-Cardiac Vascular Disease
Current Pharmaceutical Design Current Perspectives on Hypertension in Asian Indians
Current Hypertension Reviews Cardiovascular Disease Burden and Risk Factors Before and After Kidney Transplant
Cardiovascular & Hematological Disorders-Drug Targets Passive Smoking and Coronary Heart Disease
Current Vascular Pharmacology Cancer Risk and Nullity of Glutathione-S-Transferase Mu and Theta 1 in Occupational Pesticide Workers
Current Pharmaceutical Biotechnology Mechanisms of Inflammatory Atherosclerosis in Rheumatoid Arthritis
Current Immunology Reviews (Discontinued) Bioavailability of Quercetin: Problems and Promises
Current Medicinal Chemistry G-Lymphatic, Vascular and Immune Pathways for Aβ Clearance Cascade and Therapeutic Targets For Alzheimer’s Disease
Combinatorial Chemistry & High Throughput Screening Editorial [Hot Topic: New Developments in the Prevention and Treatment of Vascular Disease - 2 Executive (Guest Editors: Manfredi Rizzo and Dimitri P. Mikhailidis)]
Current Pharmaceutical Design Calcium Handling and Arrhythmogenesis
Medicinal Chemistry